Advocacy News

LRF Advocates for Patient Access to Cellular Therapies

On November 2, 2019, the Lymphoma Research Foundation sent a letter to Donald Thompson, Director, Division of Acute Care at the Centers for Medicare and Medicaid Services requesting for MS-DRG reclassification for certain cases involving the use of chimeric antigen receptor T-cell (CAR T-cell) therapies.

Congress to Consider Federal Cancer Research Budget

Every year the National Institutes of Health (NIH) and National Cancer Institute (NCI) are required to prepare for the President and the Congress its best professional judgment on the optimal funding needed to make the most rapid progress in the…

LRF Releases Monograph Addressing Early Career Scientist Crisis

In the face of declining federal and institutional resources, the Lymphoma Research Foundation’s (LRF) commitment to supporting early career lymphoma researchers has become more critical than ever before. To explore this important topic, the Foundation convened a Biden Cancer Community…

Lymphoma Research Foundation Attends White House Cancer Moonshot Meeting

New York, NY (January 6, 2017) – The Lymphoma Research Foundation’s (LRF) CEO, Meghan Gutierrez, was honored to represent the lymphoma community at the White House, during the Cancer Moonshot Open Innovation meeting, to discuss reaching Cancer Moonshot goals. Cancer Moonshot began…